QuidelOrtho

QDEL · NASDAQ

$14.21+$1.45 (+11.36%)TodayMarket closed · Oct 20, 7:48 PM ET

Prev close $12.76

Latest news

Press releaseOct 20, 8:00 AM ETPRNewswire
QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
Press releaseOct 15, 6:10 PM ETPRNewswire
QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NewsOct 13, 4:35 AM ET
QuidelOrtho Reports Q2 2026 Results: Full Earnings Call Transcript
Press releaseOct 8, 2:50 PM ETPRNewswire
Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Press releaseOct 7, 7:13 AM ETPRNewswire
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
Press releaseSep 24, 9:12 AM ETPRNewswire
Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment
Press releaseAug 27, 9:12 AM ETPRNewswire
Faster Answers, Better Decisions: ADLM 2026 Highlights
NewsAug 7, 3:19 PM ETAvi Kapoor
Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July
NewsAug 7, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 7, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsAug 7, 8:02 AM ETAvi Kapoor
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
NewsAug 7, 4:33 AM ETAvi Kapoor
Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket
NewsAug 6, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsAug 6, 4:10 PM ET
QuidelOrtho Q2 Adj. EPS $0.13 Beats $(0.05) Estimate, Sales $631.000M Beat $618.849M Estimate
Press releaseAug 6, 4:05 PM ETPRNewswire
QuidelOrtho Reports Second Quarter 2026 Financial Results
Press releaseJul 24, 7:00 AM ETPRNewswire
QuidelOrtho to Report Second Quarter 2026 Financial Results
Press releaseJul 23, 9:21 AM ETPRNewswire
Beyond Fentanyl: How the Drug Crisis Is Changing
Press releaseJul 23, 7:00 AM ETBusiness Wire
Kaskela Law Firm Announces Investigation of QuidelOrtho Corp. (QDEL) and Encourages Long-Term QDEL Shareholders with Investment Losses to Contact the Firm
Press releaseJul 15, 7:31 PM ETPRNewswire
QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Press releaseJun 23, 7:12 AM ETPRNewswire
QuidelOrtho Appoints Micah Young as Chief Financial Officer
Press releaseJun 2, 7:12 AM ETPRNewswire
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies
Press releaseMay 21, 9:18 AM ETPRNewswire
When Blood Compatibility Becomes a Pregnancy Risk
Press releaseMay 20, 7:00 AM ETPRNewswire
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences
Press releaseMay 5, 4:05 PM ETPRNewswire
QuidelOrtho Reports First Quarter 2026 Financial Results
Press releaseApr 23, 9:32 AM ETPRNewswire
Understanding and Addressing Syphilis Trends - and What's Being Missed
Press releaseApr 20, 7:56 AM ETBusiness Wire
TTP Group Announces the Sale of LEX Diagnostics
NewsApr 20, 7:30 AM ET
QuidelOrtho Completes Acquisition Of LEX Diagnostics For Cash Consideration Of ~$100M; Co. Expects To Initiate U.S. Commercial Launch Of LEX VELO System Later This Year
Press releaseApr 20, 7:12 AM ETPRNewswire
QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics
NewsApr 16, 12:26 PM ETAvi Kapoor
Crude Oil Gains Over 2%; PepsiCo Posts Upbeat Q1 Earnings
NewsApr 16, 8:07 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsApr 16, 2:41 AM ETTanya Rawat
QuidelOrtho (QDEL) Drops 20% After-Hours On Wednesday— What's Going On?
Press releaseApr 15, 4:15 PM ETPRNewswire
QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance
Press releaseMar 24, 7:00 AM ETPRNewswire
Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
Press releaseFeb 19, 9:17 AM ETPRNewswire
Faster Cardiac Answers with High‑Sensitivity Troponin
Press releaseFeb 18, 4:05 PM ETPRNewswire
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference
Press releaseFeb 11, 4:05 PM ETPRNewswire
QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results
NewsNov 21, 11:14 AM ETAvi Kapoor
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
Press releaseNov 5, 4:05 PM ETPRNewswire
QuidelOrtho Reports Third Quarter 2025 Financial Results
Press releaseNov 5, 4:05 PM ETPRNewswire
QuidelOrtho Reports Third Quarter 2025 Financial Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026

QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

QuidelOrtho Reports Q2 2026 Results: Full Earnings Call Transcript

Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?

QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations

Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment

Faster Answers, Better Decisions: ADLM 2026 Highlights

Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Thursday's After-Market Session

QuidelOrtho Q2 Adj. EPS $0.13 Beats $(0.05) Estimate, Sales $631.000M Beat $618.849M Estimate

QuidelOrtho Reports Second Quarter 2026 Financial Results

QuidelOrtho to Report Second Quarter 2026 Financial Results

Beyond Fentanyl: How the Drug Crisis Is Changing

Kaskela Law Firm Announces Investigation of QuidelOrtho Corp. (QDEL) and Encourages Long-Term QDEL Shareholders with Investment Losses to Contact the Firm

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

QuidelOrtho Appoints Micah Young as Chief Financial Officer

QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies

When Blood Compatibility Becomes a Pregnancy Risk

QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences

QuidelOrtho Reports First Quarter 2026 Financial Results

Understanding and Addressing Syphilis Trends - and What's Being Missed

TTP Group Announces the Sale of LEX Diagnostics

QuidelOrtho Completes Acquisition Of LEX Diagnostics For Cash Consideration Of ~$100M; Co. Expects To Initiate U.S. Commercial Launch Of LEX VELO System Later This Year

QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics

Crude Oil Gains Over 2%; PepsiCo Posts Upbeat Q1 Earnings

12 Health Care Stocks Moving In Thursday's Pre-Market Session

QuidelOrtho (QDEL) Drops 20% After-Hours On Wednesday— What's Going On?

QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance

Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer

Faster Cardiac Answers with High‑Sensitivity Troponin

QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference

QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results

Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday

QuidelOrtho Reports Third Quarter 2025 Financial Results

QuidelOrtho Reports Third Quarter 2025 Financial Results